Telomir Pharmaceuticals Inc (TELO)

Apr 02, 2025

Charles Schwab Investment Management Inc. Boosts Position in Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) - Defense World

Apr 02, 2025

Apr 01, 2025

TELO stock touches 52-week low at $3.1 amid market challenges By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

TELO stock touches 52-week low at $3.1 amid market challenges - Investing.com India

Apr 01, 2025

Apr 01, 2025

Virtu Financial LLC Acquires Shares of 14,959 Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) - Defense World

Apr 01, 2025

Mar 29, 2025

Bank of New York Mellon Corp Increases Stock Position in Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) - Defense World

Mar 29, 2025

Mar 25, 2025

Analyzing Telomir Pharmaceuticals (TELO) & The Competition - Defense World

Mar 25, 2025

Mar 23, 2025

Telomir Pharmaceuticals Announces Significant Anti-Cancer Effects in Prostate Cancer Animal Model Using Highly Aggressive Human Prostate Cancer Cells - Bluefield Daily Telegraph

Mar 23, 2025

Mar 21, 2025

Telomir Pharmaceuticals announces anti-cancer effects in prostate cancer animal model - MSN

Mar 21, 2025

Mar 19, 2025

SWK Holdings Announces Monetization of Royalty Portfolio - Waco Tribune-Herald

Mar 19, 2025

Mar 19, 2025

Telomir-1 shows promise in cancer and chemotherapy study By Investing.com - Investing.com South Africa

Mar 19, 2025

Mar 19, 2025

Telomir Pharmaceuticals Says Telomir-1 Reduces Tumor Size in Prostate Cancer Animal Model - MarketScreener

Mar 19, 2025

Mar 19, 2025

Telomir-1 shows promise in cancer and chemotherapy study - Investing.com

Mar 19, 2025

Mar 19, 2025

Telomir Pharmaceuticals reports breakthrough in prostate cancer treatment By Investing.com - Investing.com South Africa

Mar 19, 2025

Mar 19, 2025

Telomir Pharmaceuticals reports breakthrough in prostate cancer treatment - Investing.com India

Mar 19, 2025

Mar 19, 2025

Breakthrough: New Cancer Drug Cuts Prostate Tumors by Half While Reducing Chemo Toxicity - StockTitan

Mar 19, 2025

Mar 19, 2025

Telomir Pharmaceuticals Lead Drug Candidate Inhibits Tumor Growth In Aggressive Prostate Cancer Cells, Animal Study Shows - Benzinga

Mar 19, 2025

Mar 12, 2025

Rhumbline Advisers Boosts Position in Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) - Defense World

Mar 12, 2025

Mar 04, 2025

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) Short Interest Up 34.4% in February - Defense World

Mar 04, 2025

Feb 26, 2025

Telomir-1 shows promise in reversing cell aging By Investing.com - Investing.com South Africa

Feb 26, 2025

Feb 26, 2025

Telomir-1 shows promise in reversing cell aging - Investing.com India

Feb 26, 2025

Feb 26, 2025

Telomir Pharmaceuticals Announces Breakthrough: Telomir-1 Reverses Calcium Dysregulation, the Hidden Driver of Aging and Disease, in Multiple Human Cell Lines - Eagle-Tribune

Feb 26, 2025

Feb 26, 2025

Could This Anti-Aging Compound Revolutionize Treatment for Alzheimer's and Macular Degeneration? - StockTitan

Feb 26, 2025

Feb 25, 2025

Telomir Pharmaceuticals announces Telomir-1 reverses calcium dysregulation in multiple human cell lines - MSN

Feb 25, 2025

Feb 25, 2025

Telomir Pharmaceuticals reports key preclinical success By Investing.com - Investing.com South Africa

Feb 25, 2025

Feb 25, 2025

Telomir Pharmaceuticals reports key preclinical success - Investing.com India

Feb 25, 2025

Feb 25, 2025

Telomir Pharmaceuticals achieves breakthrough in silver ion stabilization - MSN

Feb 25, 2025

Feb 24, 2025

Telomir Pharmaceuticals (NASDAQ:TELO) Research Coverage Started at Rodman & Renshaw - Defense World

Feb 24, 2025

Feb 23, 2025

Telomir-1 exhibited strong ROS reduction properties, hold potential for AMD treatment - Ophthalmology Times

Feb 23, 2025

Feb 21, 2025

Telomir reports stabilization of silver forms for medical use By Investing.com - Investing.com Nigeria

Feb 21, 2025

Feb 21, 2025

Telomir Pharmaceuticals Says Telomir-1 Compound Stabilizes Silver for Advanced Medical Applications - Marketscreener.com

Feb 21, 2025

Feb 21, 2025

Telomir reports stabilization of silver forms for medical use - Investing.com

Feb 21, 2025

Feb 21, 2025

Telomir Pharmaceuticals Achieves Breakthrough in Silver Ion Stabilization, Unlocking a Multi-Billion-Dollar Medical Market - Weatherford Democrat

Feb 21, 2025

Feb 20, 2025

Telomir Pharmaceuticals announces silver ion breakthrough - Investing.com

Feb 20, 2025

Feb 20, 2025

Telomir Pharmaceuticals Seeks To Tap Multi-Billion-Dollar Market With Breakthrough In Silver Ion Stabilization For Antibacterial Treatment, Tissue Regeneration - Benzinga

Feb 20, 2025

Feb 18, 2025

TELO Again Announces Breakthrough Results - MSN

Feb 18, 2025

Feb 18, 2025

Telomir Pharmaceuticals Announces Significant Reduction of Oxidative Stress in Human Retinal Cell Lines, Advancing Potential Treatment for Age-Related Macular Degeneration (AMD) - Milton Daily Standard

Feb 18, 2025

Feb 10, 2025

What is Zacks Small Cap's Estimate for TELO Q1 Earnings? - MarketBeat

Feb 10, 2025

Feb 08, 2025

Telomir Pharmaceuticals (NASDAQ:TELO) Announces Earnings Results, Misses Estimates By $0.05 EPS - MarketBeat

Feb 08, 2025

Feb 08, 2025

What is Zacks Small Cap’s Estimate for TELO Q1 Earnings? - Defense World

Feb 08, 2025

Feb 04, 2025

Telomir Pharmaceuticals Inc. (TELO) reports earnings - Quartz

Feb 04, 2025

Feb 03, 2025

TELO Treatment Amazes in Preclinical Trial - MSN

Feb 03, 2025

Feb 03, 2025

Will These 5 Big Drug Stocks Surpass Q4 Earnings Forecasts? - Barchart

Feb 03, 2025

Feb 02, 2025

Telomir Pharmaceuticals Announces Major Breakthrough in Reversing Oxidative Stress, Unlocking Potential for Treating Age-Related Diseases and Viruses Like Bird Flu - Barchart

Feb 02, 2025

Jan 31, 2025

Thrombotic Thrombocytopenic Purpura Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Global Blood Therapeutics, Sanofi, Carelon Research, Archemix Corp., Eisai Inc - Barchart

Jan 31, 2025